Fulvestrant (Faslodex®) demonstrates clinical benefit in heavily pretreated postmenopausal women with advanced breast cancer:: a single-center experience.

被引：0
|
作者：
Franco, S
Perez, A
Tan-Chiu, E
Frankel, C
Vogel, C
机构：
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2003年 / 82卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
439
引用
收藏
页码：S105 / S105
页数：1
相关论文
共 50 条
  • [41] Minimal clinical benefit of single agent Orathecin (Rubitecan) in heavily pretreated metastatic breast cancer
    Silwan Chedid
    Edgardo Rivera
    Debbie K. Frye
    Nuhad Ibrahim
    Francisco Esteva
    Vicente Valero
    Gabriel Hortobagyi
    Karl L. Mettinger
    Massimo Cristofanilli
    Cancer Chemotherapy and Pharmacology, 2006, 57 : 540 - 544
  • [42] Fulvestrant in Advanced Breast Cancer Following Tamoxifen and Aromatase Inhibition: A Single Center Experience
    Wang, Jayson
    Jain, Sandeep
    Coombes, Charles R.
    Palmieri, Carlo
    BREAST JOURNAL, 2009, 15 (03): : 247 - 253
  • [43] Fulvestrant in heavily pretreated metastatic breast cancer: Is it still effective as a very advanced line of treatment?
    Safra, Tamar
    Greenberg, Julia
    Ron, Ilan G.
    Ben-Yosef, Rami
    Inbar, Moshe
    Sarid, David
    Yaal-Hahoshen, Neora
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2008, 10 (05): : 339 - 343
  • [44] Evaluation of fulvestrant (F) activity and toxicity in heavily pretreated patients with advanced breast cancer (ABC)
    Catania, C.
    Ascione, G.
    Medici, M.
    Verri, E.
    Sanna, G.
    Marenghi, C.
    Minchella, I.
    Adamoli, L.
    Goldhirsch, A.
    Nole, F.
    EJC SUPPLEMENTS, 2005, 3 (02): : 126 - 126
  • [45] Fulvestrant for the treatment of advanced breast cancer in postmenopausal women: A Japanese study
    Watanabe, T
    Sano, M
    Ohno, S
    Inaji, H
    Nishimura, R
    Shin, E
    Nomura, Y
    Morris, C
    ANTICANCER RESEARCH, 2004, 24 (2C) : 1275 - 1280
  • [46] Breast cancer diagnosis and women cancer concerns: a single-center experience
    Ben Kridis, Wala
    Toumi, Nabil
    Daoud, Emna
    Mnif, Zeineb
    Chaaben, Kais
    Boudawara, Tahia
    Daoud, Jamel
    Khanfir, Afef
    BMJ SUPPORTIVE & PALLIATIVE CARE, 2024, 14 (E3) : E3036 - E3037
  • [47] Developing a prediction model for benefit from fulvestrant in heavily pretreated metastatic breast cancer (MBC) patients
    Amir, E.
    Freedman, O. C.
    Dranitsaris, G.
    Napolskikh, J.
    Chia, S.
    Petrella, T.
    Dent, S.
    Kumar, R.
    Fralick, M.
    Clemons, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [48] Survival analysis of brain metastases secondary to breast cancer: A single-center experience.
    Chun, Brie
    Oyogoa, Emmanuella
    Kaempf, Andy
    Levy, Julia
    Lazos, Thalia Padilla
    Rounsavill, Teyhana
    Nguyen, Mai-Loan
    Stefanik, Fiona
    Eichten, Victoria
    Kornachuk, Tana
    Duong, Jessica
    Goodyear, Shaun M.
    Zimmer, Alexandra Dos Santos
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [49] Neuroendocrine breast cancer: A single center experience.
    Tasdemir, Vildan
    Kertmen, Neyran
    Cenoli, Alma
    Keskin, Ozge
    Karakas, Yusuf
    Diker, Omer
    Dizdar, Omer
    Aksoy, Sercan
    Ozisik, Yavuz
    Altundag, Kadri
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [50] Molecular testing in advanced lung adenocarcinoma: A single-center experience.
    Khan, Mahir
    Nguyen, Ryan Huu-Tuan
    Pasquinelli, Mary
    Feldman, Lawrence Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345